Tag Archives: BIO

BIOtech NOW: The Role of Intellectual Property in Global Health

The Role of Intellectual Property in Global Health BIO is committed to increase access to biologic medicines for patients throughout the world.  As BIO President and CEO Jim Greenwood said last year when announcing our policy statement on Options for Increasing Access to Medicines in the Developing World, “We believe that the goals of increasing access to medicines, respecting intellectual property rights, and maintaining commercial viability are mutually supportive.” While there are frequent misguided calls Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

The Global Biotech Industry Comes to BIO

The world’s largest biotech hubs are busy planning their delegations’ visits to the BIO International Convention next month. The international program at the Convention will be one of the most robust to date, with International Case Studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets. BIOtechNOW is profiling a few of the top delegations to give you a preview*: Australia: Australia’s biotech sector, along with the broader Australian economy, performed Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO and USPTO Trace the Journey of Biotech Inventions

BIO will be co-hosting an event with the United States Patent and Trademark Office (USPTO) to celebrate the 30th anniversary of the issuance of U.S. patent 4,259,444 to Ananda Chakrabarty following the Supreme Court case, Diamond v. Chakrabarty, which held that Chakrabarty’s bioengineered bacterium was eligible for patenting.  The event will be held during the BIO International Convention on the morning of Thursday, June 30, at the Walter E. Washington Convention Center in Washington, D.C. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO and USPTO Trace the Journey of Biotech Inventions

BIO will be co-hosting an event with the United States Patent and Trademark Office (USPTO) to celebrate the 30th anniversary of the issuance of U.S.patent 4,259,444 to Ananda Chakrabarty following the Supreme Court case, Diamond v. Chakrabarty, which held that Chakrabarty’s bioengineered bacterium was eligible for patenting.  The event will be held during the BIO International Convention on the morning of Thursday, June 30, at the Walter E.Washington Convention Center inWashington, D.C.  See the BIOtech Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Scientific American Worldview 2011 Preview – Three pioneers share keys to success for building biotech in emerging markets

Three biotech luminaries who have succeeded against all odds share their experiences building a biotech company from the ground up in Brazil, China and India. This year’s report will profile: Guilherme Emrich, FIR Capital (Brazil) Ge Li, WuXi Apptec (China) Kiran Mazumdar-Shaw, Biocon (India) Their opinions and advice on a diverse range of subjects is explored in a Q&A while their individual stories are told in accompanying profiles.  Don’t miss this special section in the Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,